Aerie Pharmaceuticals last day of trading expected Nov. 18 as part of Alcon merger

Nov. 15, 2022 4:21 PM ETAerie Pharmaceuticals, Inc. (AERI)ALCBy: Jonathan Block, SA News Editor

M&A abbreviation - mergers and acquisitions, on wooden cubes on a light background. — Nastassia Samal

Aerie Pharmaceuticals' (NASDAQ:AERI) likely last day of trading on the Nasdaq will be on Nov. 18 as part of its merger with Alcon (ALC).
With the acquisition, Alcon (ALC) gains Rocklatan and Rhopressa, eye drops to reduce intraocular pressure, as well as a pipeline of several clinical and preclinical candidates.
In August, Alcon (ALC) said it would acquire Aerie (AERI) for ~$770M.

Recommended For You

Comments

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.

Is this happening to you frequently? Please report it on our feedback forum.

If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.